NCT05786287Not yet recruiting
Long-term Safety of UC-MSC Transplantation in Patients With Retinitis Pigmentosa
Long-term Safety of Umbilical Cord-Mesenchymal Stem Cell (UC-MSC) Transplantation in Patients With Retinitis Pigmentosa
Source: ClinicalTrials.gov · Last updated 25 Feb 2026
Brief summary (registry, in English)
The study will perform to follow-up UC-MSCs and CM transplantation. 18 patients will be called back to be examined after 5 years of UC-MSC and/or CM transplantation.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 18 (estimated)
- First submitted
- 14 Mar 2023
- Start date
- 1 May 2026
- Primary completion date
- 31 Jul 2027
- Lead sponsor
- PT. Prodia Stem Cell Indonesia
- Diseases
- Retinitis pigmentosa
- NCT number
- NCT05786287
What you commit to
- Study type: Observational
- Planned participants: 18
- From 1 May 2026 to the primary completion date, 31 Jul 2027
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- In the immunosuppressive treatment or other drugs that can affect the growth of transplanted stem cells
Other illness
- Positive result of HIV test
- Have a history of eye tumours
- Have another eye disease such as diabetic retinopathy, uveitis, cataract, and glaucoma
Other
- Pregnant or nursing women
- Do not come to control according to the schedule determined by the researcher (loss to follow up)
Who the study is looking for
- Visual field defects at the initial examination with Humphrey perimetry are between 25% to 50%
- Willing to sign informed consent as research subjects
- Willing to do the peribulbar injection with mesenchymal stem cells isolated from umbilical cord tissue
- Willing to do visual field checks with Humphrey's perimetry, vision tests with Snellen boards, Optical Coherent Tomography (OCT) examinations, electroretinogram examinations and fill out a quality of life questionnaire
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Jakarta Eye Center Hospital Coordinator of this site? Confirm its status | Jakarta | Indonesia | Unknown status |
| Sardjito Hospital Coordinator of this site? Confirm its status | Yogyakarta | Indonesia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.